<DOC>
	<DOCNO>NCT00396474</DOCNO>
	<brief_summary>The purpose study demonstrate insulin sensitivity different growth hormone - treated subject small gestational age ( SGA ) SGA cohort subject match gender body mass index ( BMI ) treat growth hormone ( GH ) remain short final height .</brief_summary>
	<brief_title>Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height</brief_title>
	<detailed_description>case-control</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<criteria>Patients SGA treat growth hormone one follow Genotropin study ( 89041 , 89070/071 , 90079 , 90080/988122011 ) least 3 year stop GH treatment 510 year Untreated SGA ( base birth weight and/or length 2 standard deviation [ SDs ] gestational age ) match treat SGA body mass index ( + = 10 % ) gender : Subjects bear SGA normal final height ( within +/ 1.3 SD target height ) ; Subjects bear SGA short stature ( height SDs &gt; 1.3 target final height ) . Known diabetes type 1 2 , 1st degree relative patient diabetes type 2 Familial dyslipidemia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Small gestational age , Insulin Sensitivity Index , growth hormone treatment</keyword>
</DOC>